↓ Skip to main content

Inhibiting the inhibitors: evaluating agents targeting cancer immunosuppression

Overview of attention for article published in Expert Opinion on Biological Therapy, April 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

blogs
1 blog
patent
8 patents

Citations

dimensions_citation
71 Dimensions

Readers on

mendeley
57 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Inhibiting the inhibitors: evaluating agents targeting cancer immunosuppression
Published in
Expert Opinion on Biological Therapy, April 2010
DOI 10.1517/14712598.2010.482207
Pubmed ID
Authors

Theresa L Whiteside

Abstract

Immunotherapy of cancer has not improved disease-free or overall patient survival. The lack of concordance between immunological and clinical responses in cancer immunotherapy trials is thought to result from the pervasive presence of tumor-driven immune suppression that allows tumor to escape and that has not been adequately targeted by current therapies.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 57 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 2%
Unknown 56 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 16 28%
Student > Ph. D. Student 15 26%
Student > Bachelor 7 12%
Student > Master 6 11%
Other 3 5%
Other 4 7%
Unknown 6 11%
Readers by discipline Count As %
Medicine and Dentistry 15 26%
Agricultural and Biological Sciences 12 21%
Biochemistry, Genetics and Molecular Biology 9 16%
Pharmacology, Toxicology and Pharmaceutical Science 3 5%
Immunology and Microbiology 3 5%
Other 8 14%
Unknown 7 12%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 October 2023.
All research outputs
#2,817,593
of 23,543,207 outputs
Outputs from Expert Opinion on Biological Therapy
#156
of 1,918 outputs
Outputs of similar age
#10,871
of 97,081 outputs
Outputs of similar age from Expert Opinion on Biological Therapy
#4
of 20 outputs
Altmetric has tracked 23,543,207 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,918 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 97,081 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.